Oncozenge AB

Research Oncozenge AB (ONCOZ) on Bullrun: market cap SEK 117.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerONCOZ
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 117.96M
• Financial periodQ4 2025
• Net income-SEK 9.89M
• Free cash flow-SEK 7.88M

Valuation Snapshot

latest market cap is SEK 117.96M.

About Oncozenge AB

OncoZenge AB (publ), is a clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. The company offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was founded in 2020 and is headquartered in Bromma, Sweden.

Frequently asked questions

What is Oncozenge AB's market cap?

Oncozenge AB's market capitalization is SEK 117.96M.

What does Oncozenge AB do?

OncoZenge AB (publ), is a clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.